Close

Piper Jaffray 'Encouraged' by Unilife's (UNFI) Amgen Agreement

January 4, 2016 9:40 AM EST Send to a Friend
Piper Jaffray analyst Charles Duncan reiterated an Overweight rating and $5 price target on Unilife Corporation (NASDAQ: UNIS) following the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login